http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180126523-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dbae684c01e866958496a909712f218d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2039-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0666
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2039-0258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0651
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-8206
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0624
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M39-162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M39-0208
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M39-105
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M39-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M39-16
filingDate 2017-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e3f18ea255c73e090f3a0bd5f572286
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36c71f1b15d8b55340625616f55e1087
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f725373382ddf2678efd98e33e8795d0
publicationDate 2018-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20180126523-A
titleOfInvention On-site sterilizer and vascular connector kit
abstract Placing vascular access devices (intravenous, intraarterial, and / or intramedullary vascular access) in non-sterile environments can greatly increase the risk of infection through vascular access devices. The present invention provides an approach to achieving sterilization of the site where vascular access is attempted under non-aseptic field conditions. The present invention also provides an aseptic blood vessel connector to which an antimicrobial agent, for example, taurolidine, is pre-charged. The risk of infection is limited despite the approaching arrangement under non-aseptic field conditions, since the use of the vascular connector provides access to blood vessels and at the same time provides antibiotics.
priorityDate 2016-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012208802-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414784756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514376
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22833565

Total number of triples: 30.